Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Oragenics Inc as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- −4 vs. Q1 2025
- Shares held
- 105.3K
- −168.2K (−61.5%) vs. Q1 2025
- Total value
- $401.6K
- +$344.4K (+601.9%) vs. Q1 2025
- New holders
- 5
- 3 more added
- Sold out
- 9
- 9 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $39.2K |
| Q1 2026 | 20 | $105.8K |
| Q4 2025 | 19 | $169.3K |
| Q3 2025 | 16 | $160.5K |
| Q2 2025 | 18 | $401.6K |
| Q1 2025 | 22 | $57.2K |
| Q4 2024 | 24 | $86.0K |
| Q3 2024 | 16 | $62.2K |
| Q2 2024 | 16 | $135.6K |
| Q1 2024 | 14 | $269.2K |
| Q4 2023 | 15 | $349.5K |
| Q3 2023 | 13 | $182.1K |
| Q2 2023 | 13 | $173.5K |
| Q1 2023 | 14 | $192.4K |
| Q4 2022 | 31 | $1.08M |
| Q3 2022 | 29 | $2.48M |
| Q2 2022 | 29 | $3.06M |
| Q1 2022 | 28 | $3.62M |
| Q4 2021 | 33 | $4.96M |
| Q3 2021 | 29 | $6.82M |
| Q2 2021 | 22 | $6.63M |
| Q1 2021 | 29 | $8.27M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Oragenics Inc; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Clear Street LLC | 70,619 | $269.8K | 0.00% | +70,619 | New |
| Bank of America Corp | 15,546 | $59.4K | 0.00% | +15,338+7,374.0% | Added |
| Morgan Stanley | 11,912 | $45.5K | 0.00% | +7,319+159.4% | Added |
| FNY Investment Advisers, LLC | 2,500 | $9.00K | 0.00% | +2,500 | New |
| UBS Group AG | 1,892 | $7.23K | 0.00% | −4,093−68.4% | Reduced |
| BlackRock, Inc. | 701 | $2.68K | 0.00% | −20,358−96.7% | Reduced |
| JPMorgan Chase & Co | 681 | $2.60K | 0.00% | +495+266.1% | Added |
| Lionsbridge Wealth Management LLC | 667 | $2.55K | 0.00% | −19,333−96.7% | Reduced |
| Tower Research Capital LLC (TRC) | 665 | $2.54K | 0.00% | −6,812−91.1% | Reduced |
| Wells Fargo & Company | 34 | $130 | 0.00% | +34 | New |
| Harbour Investments, Inc. | 34 | $130 | 0.00% | +34 | New |
| SBI Securities Co., Ltd. | 10 | $38 | 0.00% | −19−65.5% | Reduced |
| Activest Wealth Management | 2 | $8 | 0.00% | −32−94.1% | Reduced |
| Evermay Wealth Management LLC | 1 | $4 | 0.00% | −1−50.0% | Reduced |
| Farther Finance Advisors, LLC | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Strategic Wealth Partners, Ltd. | 1 | $4 | 0.00% | +1 | New |
| Chesapeake Asset Management LLC | 1 | $3 | 0.00% | −2−66.7% | Reduced |
| Royal Bank of Canada | 1 | $0 | 0.00% | −2−66.7% | Reduced |
| Geode Capital Management, LLC | 0 | $0 | 0.00% | −84,826−100.0% | Sold out |
| GSB Wealth Management, LLC | 0 | $0 | 0.00% | −30,927−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −25,107−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −24,845−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −18,231−100.0% | Sold out |
| Mutual Advisors, LLC | 0 | $0 | 0.00% | −16,000−100.0% | Sold out |
| HBK Sorce Advisory LLC | 0 | $0 | 0.00% | −13,626−100.0% | Sold out |
| Hexagon Capital Partners LLC | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| GWM Advisors LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |